Hyderabad is already on the global network of vaccine manufacturers. Now the city has got another remarkable opportunity to be the vaccine destination of the world. The QUAD, comprising India, the US, Australia and Japan has chosen Biological E. Limited to produce a billion doses of Covid-19 vaccine by 2022 to all the countries in the Indo-Pacific region.
The decision was taken in the first Quad leaders summit that was held on the 12th of March 2021. Accordingly, The United States and Australia will provide financial assistance to Biological E.Above all, the Hyderabad based company is chosen as it is a woman-run business. Set up by Dr DVK Raju, Mahima Datla from the third generation of the family is managing the company.
Established in 1953, Biological E. Limited is the first private company to enter the vaccine business in the country in the year 1962. Hyderabad’s pharmaceutical company will now manufacture US-based Johnson and Johnson’s vaccine. So, it is a major takeaway for India from the Quad’s meeting and it helps the country to play a major geopolitical role in the region.